Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926481 · ClinicalTrials.gov registry record · NA
Evaluation of the Healthy Lifestyle Program on Cognitive Outcomes
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03926481: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT03926481 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03926481, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to conduct a program of pilot research aimed at evaluating the effect of an intensive lifestyle intervention on cognitive functioning in older adults with obesity and or obesity and sarcopenia.
Primary Outcome
Assessed by a Jamar dynamometer. Sensor-based Thera-bands will measure data on strength change. A higher score represents a better outcome.
Interventions
- BEHAVIORAL Evaluate Healthy Lifestyle Program on cognitive outcomes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-07-10 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
Why NCT03926481 stopped before completion
NCT03926481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Evaluate Healthy Lifestyle Program on cognitive outcomes is the first listed.
NCT03926481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03926481 about?
NCT03926481 is a clinical study titled "Evaluation of the Healthy Lifestyle Program on Cognitive Outcomes". The goal of this study is to conduct a program of pilot research aimed at evaluating the effect of an intensive lifestyle intervention on cognitive functioning in older adults with obesity and or obesity and sarcopenia.
What is the current status of trial NCT03926481?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2019-07-10. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT03926481?
The interventions under investigation include: Evaluate Healthy Lifestyle Program on cognitive outcomes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03926481?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03926481's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI